Compare Repligen Corporation Common Stock (RGEN) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Shopify Inc. — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Shopify Inc. trades at $168.64 (market cap $227.12B). The key difference: Shopify Inc. is far larger — about 20.4× Repligen Corporation Common Stock's market cap, and Shopify Inc. is more actively traded (6,965,160 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Shopify Inc. for 78 Days on average.
| RGEN | SHOP | |
|---|---|---|
Market Cap | $11.14B | $227.12B |
Volume | 1,259,263 | 6,965,160 |
Sector | Health | Technology |
52-Week High | $194.57 | $179.22 |
52-Week Low | $102.87 | $95.40 |
Typical Hold Time | 0 Days | 78 Days |
Enterprise Value | $11.02B | $222.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Shopify trades at $176.43, down 1.56% on the day, with strong technical momentum showing bullish moving averages despite overbought RSI readings. The company demonstrates robust revenue growth from $5.6B in 2022 to $11.6B in 2025, with net income turning positive at $1.23B. Recent developments include the launch of Canvas AI store-building tool and strategic moves in AI-powered commerce positioning.
Shopify presents a compelling growth story with accelerating merchant solutions and subscription revenues, though valuation multiples remain elevated. Key risks include competitive pressures from Amazon and execution challenges in AI integration. Analyst consensus remains bullish with 67% buy ratings, though the current price sits near the consensus target of $174.58.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
